Press Releases
Almac Introduces selectAZyme
Almac’s biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of...
Industry Reports
Impax Laboratories Reports First Quarter 2011 Financial Results
Impax Laboratories, Inc.reported first quarter ended March 31, 2011 financial results. Larry Hsu, Ph.D., president and CEO, Impax Laboratories, Inc. said, Our revenue related...
News
Seattle Genetics Announces Approval For FDA Accepts Brentuximab Vedotin BLAs
Seattle Genetics, Inc. announced that the U.S. Food and Drug Administration has accepted for filing two Biologics License Applications (BLAs) for brentuximab vedotin, including...
Clinical Trials
FDA approves linagliptin tablets for the treatment of type 2 diabetes
Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used...
News
Teva to Acquire Cephalon in $6.8 Billion Transaction
Teva Pharmaceutical Industries Ltd. and Cephalon, Inc.announced that their Boards of Directors have unanimously approved a definitive agreement under which Teva will acquire all...
News
Ranbaxy Launches Generic Olanzapine Tablets in Spain
Ranbaxy Laboratories Limited announced the Day-1 launch of Olanzapine Tablets, the generic version of Zyprexa. Ranbaxy will be introducing Olanzapine tablets 2.5mg, 5mg, 7.5mg...
Press Releases
ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of Bepotastine Besilate Nasal Spray
ISTA Pharmaceuticals, Inc. announced positive, topline results from its Phase 2 dose-ranging, environmental clinical trial of bepotastine besilate nasal spray for the treatment of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read